On June 3, 2022, Harvard Researcher, David Corey, Ph. D. (right), Laurie Kirkegaard, NPL Impact Agency (next to David Corey), Sarah Gauch Development Associate (third from left), Board Vice-Chair, Elliot Chaikof, MD, Ph. D. (left), Melissa Chaikof, Board Chair (head of table) and Frank Gentile, Ph. D. Board member and bio tech funder (second from left) formulated a three-year plan to achieve goals for the Collaborative including fundraising initiatives. Usher 1F Syndrome is a rare disease where children are born deaf and later learn that they will lose their vision.
